Advisory Services Network’s Amneal Pharmaceuticals AMRX Stock Holding History

Advisory Services Network’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,015	Closed	-$62.3K	–	2260
2026 Q1	$62.3K	Buy	+5,015	New	+$67.3K	﹤0.01%	2489
2025 Q4	–	Sell	-5,015	Closed	-$50.2K	–	1895
2025 Q3	$50.2K	Buy	+5,015	New	+$45K	﹤0.01%	2460
2021 Q3	–	Sell	-1,000	Closed	-$5K	–	1462
2021 Q2	$5K	Buy	+1,000	New	+$5.68K	﹤0.01%	3041
2021 Q1	–	Sell	-675	Closed	-$3K	–	1350
2020 Q4	$3K	Sell	675 -362	-35%	-$1.6K	﹤0.01%	2846
2020 Q3	$4K	Buy	+1,037	New	+$4.43K	﹤0.01%	2822
2020 Q1	–	Sell	-40	Closed	–	–	3009
2019 Q4	$0	Hold	40	–	–	﹤0.01%	3067
2019 Q3	$0	Hold	40	–	–	﹤0.01%	2793
2019 Q2	$0	Sell	40 -137	-77%	-$1.4K	﹤0.01%	2791
2019 Q1	$3K	Sell	177 -260	-59%	-$3.44K	﹤0.01%	2214
2018 Q4	$6K	Buy	437 +347	+386%	+$6.25K	﹤0.01%	1941
2018 Q3	$2K	Buy	+90	New	+$1.89K	﹤0.01%	2286

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Advisory Services Network's AMRX Position: Q2 2026 in Review

Advisory Services Network sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 5,015 shares — an estimated $62.3K sold.

Advisory Services Network first reported a position in AMRX in Q3 2018 and held it in 11 quarters. The position peaked at $62.3K in Q1 2026. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Advisory Services Network reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 5,015 Amneal Pharmaceuticals shares in Q2 2026, an estimated $62.3K.
Advisory Services Network first reported a position in Amneal Pharmaceuticals in Q3 2018 and held it in 11 quarters.
Advisory Services Network's Amneal Pharmaceuticals position peaked at $62.3K in Q1 2026.
310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.